5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 30.30▼ | 30.30▼ | 30.30▼ | 30.29▼ | 29.96▲ |
MA10 | 30.29▼ | 30.23▲ | 30.23▲ | 30.28▼ | 29.13▲ |
MA20 | 29.98▲ | 29.81▲ | 29.76▲ | 30.00▲ | 27.92▲ |
MA50 | 28.83▲ | 28.29▲ | 28.23▲ | 28.70▲ | 26.90▲ |
MA100 | N/A | N/A | N/A | 27.74▲ | N/A |
MA200 | N/A | N/A | N/A | 27.06▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.046▼ | -0.042▼ | -0.037▼ | -0.061▼ | 0.301▲ |
RSI | 63.841▲ | 65.158▲ | 65.007▲ | 59.886▲ | 70.342▲ |
STOCH | 58.155 | 65.738 | 61.970 | 40.274 | 79.539 |
WILL %R | -29.311 | -54.487 | -54.487 | -80.872▼ | -31.467 |
CCI | 36.118 | 44.166 | 43.202 | -38.487 | 115.808▲ |
Wednesday, May 28, 2025 05:00 PM
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Free Report) – Zacks Small Cap issued their Q2 2025 earnings per share estimates for shares of Brainstorm Cell Therapeutics in a report issued ...
|
Monday, May 26, 2025 05:00 PM
NEW YORK, May 27, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that it ...
|
Tuesday, May 20, 2025 05:17 AM
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2025 Earnings Call Transcript May 19, 2025 Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2025 Conference Call.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 30.22 | 30.239 | 30.13 | 30.164 | 6,200 |
12/06/25 | 31.85 | 32.76 | 30.4301 | 30.4803 | 6,543 |
11/06/25 | 30.27 | 30.47 | 30.27 | 30.3444 | 5,147 |
09/06/25 | 30.33 | 30.33 | 30.22 | 30.28 | 5,500 |
06/06/25 | 30.22 | 30.27 | 30.14 | 30.187 | 23,800 |
05/06/25 | 30.54 | 30.54 | 30.231 | 30.258 | 3,000 |
04/06/25 | 30.40 | 30.40 | 30.33 | 30.3675 | 2,889 |
03/06/25 | 30.39 | 30.39 | 30.1415 | 30.19 | 17,775 |
02/06/25 | 30.30 | 30.436 | 30.2701 | 30.436 | 2,387 |
30/05/25 | 30.00 | 30.089 | 29.935 | 30.056 | 7,475 |
|
|
||||
|
|
||||
|
|